4//SEC Filing
Sablich Kim 4
Accession 0001765581-21-000125
CIK 0001232524other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 7:30 PM ET
Size
5.0 KB
Accession
0001765581-21-000125
Insider Transaction Report
Form 4
Sablich Kim
EVP & GM, North America
Transactions
- Sale
Ordinary Shares
2021-11-11$135.01/sh−2,748$371,000→ 21,135 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.075, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001758790
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 7:30 PM ET
- Size
- 5.0 KB